Outcome of stereotactic radiotherapy for patients with uncontrolled acromegaly

Canadian Journal of Neurological Sciences

Volumn 36, Issue 4, 2009, Pages 468-474

  Imran, Syed ^a   Fleetwood, Ian ^a   O'Connell, Colleen ^a   Ransom, Thomas ^a   Mulroy, Liam ^a   Ur, Ehud ^a   Clarke, David ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; GROWTH HORMONE; HYPOPHYSIS HORMONE; SOMATOMEDIN BINDING PROTEIN;

ACROMEGALY; ADRENAL DISEASE; ADULT; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; EXPERIENCE; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPOADRENALISM; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; SELLA TURCICA; STEREOTACTIC BODY RADIATION THERAPY; TREATMENT OUTCOME; TUMOR VOLUME; VISUAL FIELD;

EID: 68349099976     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100007800     Document Type: Article

References (34)

1. Gramegna A. Revue neurologique. 1909; (17):15-7.
2. Landolt AM, Haller D, Lomax N, Scheib S, Schubiger O, Siegfried J, et al. Stereotactic radiosurgery for recurrent surgically treated acromegaly: comparison with fractionated radiotherapy. J Neurosurg. 1998 Jun; 88(6): 1002-8.
3. Losa M, Gioia L, Picozzi P, Franzin A, Valle M, Giovanelli M, et al. The role of stereotactic radiotherapy in patients with growth hormone-secreting pituitary adenoma. J Clin Endocrinol Metab. 2008 Jul; 93(7): 2546-52.
4. Vik-Mo EO, Oksnes M, Pedersen PH, Wentzel-Larsen T, Rodahl E, Thorsen F, et al. Gamma knife stereotactic radiosurgery for acromegaly. Eur J Endocrinol. 2007 Sep; 157(3): 255-63.
5. Robar JL, Clark BG, Schella JW, Kim CS. Analysis of patient repositioning accuracy in precision radiation therapy using automated image fusion. J Appl Clin Med Phys. 2005; 6(1): 71-83.
6. Giustina A, Barkan A, Casanueva FF, Cavagnini F, Frohman L, Ho K, et al. Criteria for cure of acromegaly: a consensus statement. J Clin Endocrinol Metab. 2000 Feb; 85(2): 526-9.
7. Gittoes NJ, Sheppard MC, Johnson AP, Stewart PM. Outcome of surgery for acromegaly--the experience of a dedicated pituitary surgeon. Q J Med. 1999 Dec; 92(12): 741-5.
8. Shimon I, Cohen ZR, Ram Z, Hadani M. Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery. 2001 Jun; 48(6): 1239-43.
9. Melmed S. Medical progress: acromegaly. N Engl J Med. 2006 Dec 14; 355(24): 2558-73.
10. Jaffe CA, Barkan AL. Treatment of acromegaly with dopamine agonists. Endocrinol Metab Clin North Am. 1992 Sep; 21(3): 713-35.
11. Jackson SN, Fowler J, Howlett TA. Cabergoline treatment of acromegaly: a preliminary dose finding study. Clin Endocrinol (Oxf). 1997 Jun; 46(6): 745-9.
12. Freda PU. Somatostatin analogs in acromegaly. J Clin Endocrinol Metab. 2002 Jul; 87(7): 3013-8.
13. Trainer PJ, Drake WM, Katznelson L, Freda PU, Herman-Bonert V, van der Lely AJ, et al. Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. N Engl J Med. 2000 Apr 20; 342(16): 1171-7.
14. van der Lely AJ, Hutson RK, Trainer PJ, Besser GM, Barkan AL, Katznelson L, et al. Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist. Lancet. 2001 Nov 24; 358(9295): 1754-9.
15. Castinetti F, Taieb D, Kuhn JM, Chanson P, Tamura M, Jaquet P, et al. Outcome of gamma knife radiosurgery in 82 patients with acromegaly: correlation with initial hypersecretion. J Clin Endocrinol Metab. 2005 Aug; 90(8): 4483-8.
16. Jenkins PJ, Bates P, Carson MN, Stewart PM, Wass JA. Conventional pituitary irradiation is effective in lowering serum growth hormone and insulin-like growth factor-I in patients with acromegaly. J Clin Endocrinol Metab. 2006 Apr; 91(4): 1239-45.
17. Barkan AL, Halasz I, Dornfeld KJ, Jaffe CA, Friberg RD, Chandler WF, et al. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly. J Clin Endocrinol Metab. 1997 Oct; 82(10): 3187-91.
18. Cozzi R, Barausse M, Asnaghi D, Dallabonzana D, Lodrini S, Attanasio R. Failure of radiotherapy in acromegaly. Eur J Endocrinol. 2001 Dec; 145(6): 717-26.
19. Brada M, Ford D, Ashley S, Bliss JM, Crowley S, Mason M, et al. Risk of second brain tumour after conservative surgery and radiotherapy for pituitary adenoma. Br Med J. 1992 May 23; 304 (6838): 1343-6.
20. Simmons NE, Laws ER, Jr. Glioma occurrence after sellar irradiation: case report and review. Neurosurgery. 1998 Jan; 42 (1): 172-8.
21. Wass JA. Evidence for the effectiveness of radiotherapy in the treatment of acromegaly. J Endocrinol. 1997 Oct; 155 Suppl 1: S57-8.
22. Plowman PN. Pituitary adenoma radiotherapy-when, who and how? Clin Endocrinol (Oxf). 1999 Sep; 51(3): 265-71.
23. Pollock BE, Kondziolka D, Lunsford LD, Flickinger JC. Stereotactic radiosurgery for pituitary adenomas: imaging, visual and endocrine results. Acta Neurochir Suppl. 1994; 62: 33-8.
24. Hayashi M, Izawa M, Hiyama H, Nakamura S, Atsuchi S, Sato H, et al. Gamma Knife radiosurgery for pituitary adenomas. Stereotact Funct Neurosurg. 1999; 72 Suppl 1: 111-8.
25. Zhang N, Pan L, Wang EM, Dai JZ, Wang BJ, Cai PW. Radiosurgery for growth hormone-producing pituitary adenomas. J Neurosurg. 2000 Dec; 93 Suppl 3: 6-9.
26. Jezkova J, Marek J, Hana V, Krsek M, Weiss V, Vladyka V, et al. Gamma knife radiosurgery for acromegaly--long-term experience. Clin Endocrinol (Oxf). 2006 May; 64(5): 588-95.
27. Powell JS, Wardlaw SL, Post KD, Freda PU. Outcome of radiotherapy for acromegaly using normalization of insulin-like growth factor I to define cure. J Clin Endocrinol Metab. 2000 May; 85(5): 2068-71.
28. Jackson IM, Noren G. Role of gamma knife therapy in the management of pituitary tumors. Endocrinol Metab Clin North Am. 1999 Mar; 28(1): 133-42.
29. Ikeda H, Jokura H, Yoshimoto T. Transsphenoidal surgery and adjuvant gamma knife treatment for growth hormone-secreting pituitary adenoma. J Neurosurg. 2001 Aug; 95 (2): 285-91.
30. Attanasio R, Baldelli R, Pivonello R, Grottoli S, Bocca L, Gasco V, et al. Lanreotide 60 mg, a new long-acting formulation: effectiveness in the chronic treatment of acromegaly. J Clin Endocrinol Metab. 2003 Nov; 88(11): 5258-65.
31. McClelland S, III, Higgins PD, Gerbi BJ, Orner JB, Hall WA. Fractionated stereotactic radiotherapy for pituitary adenomas following microsurgical resection: safety and efficacy. Technol Cancer Res Treat. 2007 Jun; 6(3): 177-80.
32. Landolt AM, Lomax N, Scheib SG, Wellis G. Endocrine results of gamma knife radiosurgery in acromegaly and prolactinomas. In: Kondziolka D, editor. Radiosurgery. Basel: 2002. p. 87-92.
33. Pollock BE, Jacob JT, Brown PD, Nippoldt TB. Radiosurgery of growth hormone-producing pituitary adenomas: factors associated with biochemical remission. J Neurosurg. 2007 May; 106(5): 833-8.
34. Attanasio R, Epaminonda P, Motti E, Giugni E, Ventrella L, Cozzi R, et al. Gamma-knife radiosurgery in acromegaly: a 4-year follow-up study. J Clin Endocrinol Metab. 2003 Jul; 88(7): 3105-12.